Evaluating drug efficacy and toxicology in three dimensions: Using synthetic extracellular matrices in drug discovery

Accounts of Chemical Research

Volumn 41, Issue 1, 2008, Pages 139-148

  Prestwich, Glenn D ^a,b  

^a UNIVERSITY OF UTAH   (United States)

^b Glycosan BioSystems Inc   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT;

ANIMAL; ARTICLE; CHEMICAL STRUCTURE; CHEMISTRY; CULTURE TECHNIQUE; DRUG DESIGN; DRUG SCREENING; EXTRACELLULAR MATRIX; HUMAN; METABOLISM; METHODOLOGY; NEOPLASM; TISSUE ENGINEERING;

ANIMALS; ANTINEOPLASTIC AGENTS; CELL CULTURE TECHNIQUES; DRUG DESIGN; EXTRACELLULAR MATRIX; HUMANS; MOLECULAR STRUCTURE; NEOPLASMS; TISSUE ENGINEERING; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 38349143408     PISSN: 00014842     EISSN: None     Source Type: Journal    
DOI: 10.1021/ar7000827     Document Type: Article

References (63)

1. Shu, X. Z.; Prestwich, G. D. Therapeutic biomaterials from chemically modified hyaluronan. In Chemistry and Biology of Hyaluronan; Garg, H. G., Hales, C. A., Eds.; Elsevier Press: Amsterdam, The Netherlands, 2004; pp 475-504.
2. Prestwich, G. D.; Shu, X. Z.; Liu, Y.; Cai, S.; Walsh, J. F.; Hughes, C. W.; Kirker, K. R.; Orlandi, R. R.; Park, A. H.; Thibeault, S. L.; Smith, M. E. Injectable synthetic extracellular matrices for tissue engineering and repair. Adv. Exp. Med. Biol. 2006, 585, 125-133.
3. Luo, Y.; Prestwich, G. D. Novel biomaterials for drug delivery. Expert Opin. Ther. Pat. 2001, 11, 1395-1410.
4. Allison, D.; Grande-Allen, K. Hyaluronan: A powerful tissue engineering tool. Biomaterials 2006, 12, 2131-2140.
5. Shu, X. Z.; Ahmad, S.; Liu, Y.; Prestwich, G. D. Synthesis and evaluation of injectable, in situ crosslinkable synthetic extracellular matrices (sECMs) for tissue engineering. J. Biomed. Mater. Res. 2006, 79, 902-912.
6. Prestwich, G. D.; Liu, Y.; Yu, B.; Shu, X. Z.; Scott, A. 3D culture in synthetic extracellular matrices: New tissue models for drug toxicology and cancer drug discovery. Adv. Enz. Reg. 2007, in press.
7. Pouyani, T.; Harbison, G. S.; Prestwich, G. D. Novel hydrogels of hyaluronic acid: Synthesis, surface morphology, and solid-state NMR. J. Am. Chem. Soc. 1994, 116, 7515-7522.
8. Shu, X. Z.; Liu, Y.; Luo, Y.; Roberts, M. C.; Prestwich, G. D. Disulfide cross-linked hyaluronan hydrogels. Biomacromolecules 2002, 3, 1304-1311.
9. Shu, X. Z.; Liu, Y.; Palumbo, F. S.; Luo, Y.; Prestwich, G. D. In situ crosslinkable hyaluronan hydrogels for tissue engineering. Biomaterials 2004, 25, 1339-1348.
10. Shu, X. Z.; Liu, Y.; Palumbo, F.; Prestwich, G. D. Disulfide-crosslinked hyaluronangelatin hydrogel films: A covalent mimic of the extracellular matrix for in vitro cell growth. Biomaterials 2003, 24, 3825-3834.
11. Shu, X. Z.; Ghosh, K.; Liu, Y.; Palumbo, F. S.; Luo, Y.; Clark, R. A.; Prestwich, G. D. Attachment and spreading of fibroblasts on an RGD peptide-modified injectable hyaluronan hydrogel. J. Biomed. Mater. Res. 2004, 68, 365-375.
12. Ghosh, K.; Ren, X.-D.; Shu, X. Z.; Prestwich, G. D.; Clark, R. A. F. Fibronectin functional domains coupled to hyaluronan stimulate primary human dermal fibroblast responses critical for wound healing. Tissue Eng. 2006, 12, 601-613.
13. Cai, S.; Liu, Y.; Shu, X. Z.; Prestwich, G. D. Injectable glycosaminoglycan hydrogels for controlled release of human basic fibroblast growth factor. Biomaterials 2005, 26 (30), 6054-6067.
14. Pike, D. B.; Cai, S.; Pomraning, K. R.; Firpo, M. A.; Fisher, R. J.; Shu, X. Z.; Prestwich, G. D.; Peattie, R. A. Heparin-regulated release of growth factors in vitro and angiogenic response in vivo to implanted hyaluronan hydrogels containing VEGF and bFGF. Biomaterials 2006, 27, 5242-5251.
15. Riley, C. M.; Fuegy, P. W.; Firpo, M. A.; Shu, X. Z.; Prestwich, G. D.; Peattie, R. A. Stimulation of in vivo angiogenesis using dual growth factor-loaded crosslinked glycosaminoglycan hydrogels. Biomaterials 2006, 27, 5935-5943.
16. Orlandi, R.; Shu, X.; McGill, L.; Petersen, E.; Prestwich, G. D. Structural variations in a single hyalruonan derivative significantly alter wound-healing effects in the rabbit maxillary sinus. Laryngoscope 2007, 117, 1288-1295.
17. Liu, Y.; Shu, X. Z.; Prestwich, G. D. Reduced post-operative intra-abdominal adhesions using Carbylan™-SX, a semi-synthetic glycosaminoglycan hydrogel. Fertil. Steril. 2007, 87, 940-948.
18. Prestwich, G. D. Simplifying the extracellular matrix for 3D cell culture and tissue engineering: A pragmatic approach. J. Cell. Biochem. 2007, DOI 10.1002/jcb21386.
19. Duflo, S.; Thibeault, S. L.; Li, W.; Shu, X. Z.; Prestwich, G. D. Vocal fold tissue repair in vivo using a synthetic extracellular matrix. Tissue Eng. 2006, 12, 2171-2180.
20. Liu, Y.; Ahmad, S.; Shu, X. Z.; Sanders, R. K.; Kopesec, S. A.; Prestwich, G. D. Accelerated repair of cortical bone defects using a synthetic extracellular matrix to deliver human demineralized bone matrix. J. Orthop. Res. 2006, 24, 1454-1462.
21. Liu, Y.; Shu, X. Z.; Prestwich, G. D. Osteochondral defect repair with autologous bone marrow-derived mesenchymal stem cells in an injectable, in situ crosslinked synthetic extracellular matrix, Tissue Eng. 2006, 3405-3416.
22. Liu, Y.; Cai, S.; Shu, X. Z.; Shelby, J.; Prestwich, G. D. Sustained release of basic fibroblast growth factor from a crosslinked glycosaminoglycan hydrogel promotes wound healing in genetically diabetic mice. Wound Repair Regen. 2007, 15, 245-251.
23. Flaim, C.; Chien, S.; Bhatia, S. An extracellular matrix microarray for probing cellular differentiation. Nature Methods 2005, 2, 119-125.
24. Mehra, T. D.; Ghosh, K.; Shu, X. Z.; Prestwich, G. D.; Clark, R. A. F. Molecular stenting with a crosslinked hyaluronan derivative inhibits collagen gel contraction. J. Invest. Dermatol. 2006, 126, 2202-2209.
25. Reid, L.; Yao, H.-I.; Cheng, N. Stem cells and maturational lineage biology: Implications for clinical, research, and commercial programs. In Principles of Tissue Engineering; Atala, A., Ed.; Elsevier: San Diego, CA, 2007; in press.
26. Discher, D.; Janmey, P.; Wang, Y.-I. Tissue cells feel and respond to the stiffness of their substrate. Science 2005, 310, 1139-1143.
27. Engler, A.; Sen, S.; Sweeney, H.; Discher, D. Matrix elasticity directs stem cell lineage specification. Cell 2006, 126, 677-689.
28. Ghosh, K.; Pan, Z.; Guan, E.; Ge, S.; Liu, Y.; Nakamura, T.; Ren, X.-D.; Rafailovich, M. H.; Clark, R. A. F. Cell adaptation to a physiologically relevant ECM mimic with different viscoelastic properties. Biomaterials 2007, 28, 671-679.
29. Mironov, V.; Kasyanov, V.; Shu, X. Z.; Eisenberg, C.; Eisenber, L.; Gonda, S.; Trusk, T.; Markwald, R. R.; Prestwich, G. D. Fabrication of tubular tissue construct by centrifugal casting of cells suspended in an in situ crosslinkable hyaluronan hydrogel. Biomaterials 2005, 26, 7628-7635.
30. Griffith, L.; Swartz, M. Capturing complex 3D tissue physiology in vitro. Nat. Rev. Mol. Cell Biol. 2006, 7, 211-224.
31. Cukierman, E.; Pankov, R.; Stevens, D. R.; Yamada, K. M. Taking cell-matrix adhesions to the third dimension. Science 2001, 294, 1708-1712.
32. Elsdale, T.; Bard, J. Collagen substrata for studies on cell behavior. J. Cell Biol. 1972, 54, 626-637.
33. Grinnell, F.; CHo, C.-H.; Tamariz, E.; Lee, D.; Skuta, G. Dendritic fibroblasts in three-dimensional collagen matrices. Mol. Biol. Cell 2003, 14, 384-395.
34. Tranquillo, R. Self-organization of tissue-equivalents: The nature and role of contact guidance. Biochem. Soc. Symp. 1999, 65, 27-42.
35. Bissell, M. Modelling molecular mechanisms of breast cancer and invasion: Lessons from the normal gland. Biochem. Soc. Trans. 2006, 35, 18-22.
36. Jacks, T.; Weinberg, R. Taking the study of cancer cell survival to a new dimension. Cell 2002, 111, 923-925.
37. Kleinman, H.; McGarvey, M.; Hassell, J.; Star, V.; Cannon, F.; Laurie, G.; Martin, G. Basement membrane complexes with biological activity. Biochemistry 1986, 25, 312-318.
38. Li, M. L.; Aggeler, J.; Farson, D. A.; Hatier, C.; Hassell, J.; Bissell, M. J. Influence of a reconstituted basement membrane and its components on casein gene expression and secretion in mouse mammary epithelial cells. Proc. Natl. Acad. Sci. U.S.A. 1987, 84, 136-140.
39. Debnath, J.; Brugge, J. Modelling glandular epithelial cancers in three-dimensional cultures. Nat. Rev. Cancer 2005, 5, 675-688.
40. Imming, P.; Sinning, C.; Meyer, A. Drugs, their targets and the nature and number of drug targets. Nat. Rev. Drug Discovery 2006, 5, 821-834.
41. Gallagher, W.; Lynch, I.; Allen, L.; Miller, I.; Penney, S.; O'Conner, D.; Pennington, S.; Keenan, A.; Dawson, K. Molecular basis of cell-biomateriai interaction: Insights gained from transciptomic and proteomic studies. Biomaterials 2006, 27, 5871-5882.
42. Klapperich, C.; Bertozzi, C. Global gene expression of cells attached to a tissue engineering scaffold. Biomaterials 2004, 25, 5631-5641.
43. Park, T.-H.; Shuler, M. Integration of cell culture and microfabrication technology. Biotechnol. Prog. 2003, 19, 243-253.
44. Tanaka, Y.; Sato, K.; Shimizu, T.; Yamato, M.; Okano, T.; Kitamori, T. A microspherical heart pump powered by cultured cardiomyocytes. Lab Chip 2007, 7, 207-212.
45. Allen, J.; Hassanein, T.; Bhatia, S. Advances in bioartificial liver devices. Hepatology 2001, 34, 447-455.
46. Tanaka, Y.; Sato, K.; Yamato, M.; Okano, T.; Kitamori, T. Drug response system in a microchip using human hepatoma cells. Anal. Sci. 2004, 20, 411-413.
47. Albrecht, D.; Tsang, V.; Sah, R.; Bhatia, S. Photo- and electropatterning of hydrogel-encapsulated living cell arrays. Lab Chip 2005, 5, 111-118.
48. Liu, Y.; Shu, X. Z.; Prestwich, G. D. Tumor engineering: Orthotopic cancer models in mice using cell-loaded injectable crosslinked, hyaluronan-derived hydrogels. Tissue Eng. 2007, 13, 1091-1101.
49. Li, A. Accurate prediction of human drug toxicity: A major challenge in drug development. Chem.-Biol Interact. 2004, 150, 3-7.
50. DiMasi, J. The price of innovation: New estimates of drug development costs. J. Health Econ. 2003, 22, 151-185.
51. Friedman, D. The silicon guinea pig. Technol. Rev. 2004, June, 62-68.
52. Dambach, D.; Andrews, B.; Mouin, F. New technologies and screening strategies for hepatotoxicity: Use of in vitro models. Toxicol. Pathol. 2005, 33, 17-26.
53. Hamilton, G.; Jolley, S.; Gilbert, D.; Coon, D.; Barros, S.; LeCluyse, E. Regulation of cell morphology and cytochrome P450 expression in human hepatocytes by extracellular matrix and cell-cell interactions. Cell Tissue Res. 2001, 306, 85-89.
54. Bhadriraju, K.; Chen, C. S. Engineering cellular micraenvironments to improve cell-based drug testing. Drug Discovery Today 2002, 7, 612-620.
55. Guengerich, F. A malleable catalyst dominates the metabolism of drugs. Proc. Natl. Acad. Sci. U.S.A. 2006, 103, 13565-13566.
56. Mooney, D. J.; Hansen, L.; Vacanti, J.; Langer, R.; Farmer, S.; Ingber, D. Switching from differentiation to growth in hepatocytes: Control by extracellular matrix. J. Cell. Physiol. 1992, 151, 497-505.
57. Lazaro, C.; Croager, E.; Mitchel, C.; Campbell, J.; Yu, C.; Foraker, J.; Rhim, J.; Heoh, G.; Fausto, N. Establishment, characterization, and long-term maintenance of cultures of human fetal hepatocytes. Hepatology 2003, 38, 1095-1106.
58. Abu-Absi, S.; Friend, J.; Hansen, J. K.; Hu, W.-S. Structural polarity and functional bile canaliculi in rat hepatocyte spheroids. Exp. Cell Res. 2002, 274, 56-67.
59. Griffith, L.; Naughton, G. Tissue engineering - Current challenges and expanding opportunities. Science 2002, 295, 1009-1014.
60. Sausville, E. A.; Burger, A. M. Contributions of human tumor xenografts to anticancer drug development. Cancer Res. 2006, 66, 3351-3354.
61. Kerbel, R. S. Human tumor xenografts as predictive preclinical models for anticancer drug activity in humans: Better than commonly perceived but they can be improved. Cancer Biol. Ther. 2003, 2, S134-S139.
62. Fu, X. Y.; Besterman, J. M.; Monosov, A.; Hoffman, R. M. Models of human metastatic colon cancer in nude mice orthotopically constructed by using histologically intact patient specimens. Proc. Natl. Acad. Sci. U.S.A. 1991, 88, 9345-9349.
63. Kiguchi, K.; Kubota, T.; Aoki, D.; Udagawa, Y.; Yamanouchi, S.; Saga, M.; Amemiya, A.; Sun, F. X.; Nozawa, S.; Moossa, A. R.; Hoffman, R. M. A patient-like orthotopic implantation nude mouse model of highly metastatic human ovarian cancer. Clin. Exp. Metastasis 1998, 16, 751-756.